Announce Date | 06/18/2024 |
EPS Normalized Actual | $0.06 In Line |
EPS GAAP Actual | $0.06 In Line |
Revenue Actual | $0.291898B |
Revenue Surprise | Beat by $291.898M |
Announce Date | 07/30/2024 (Pre-Market) |
EPS Normalized Estimate | $0.54333 |
EPS GAAP Estimate | $0.54333 |
Revenue Estimate | $0.378867333B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Apr 2026 | 10.8 | 6.32 | 10.8 | 10.8 | 1 |
Apr 2025 | 6.4925 | 10.52 | 3.75 | 7.84 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2022 (Jan 2022) | 2.89 | 2.89 | 0.291898B | 21.8% | 291.9M |
FQ4 2021 (Oct 2021) | 3.5 | 3.5 | 0.288301B | 22.53% | 288.3M |
FQ3 2021 (Jul 2021) | 3.78 | 3.78 | 0.280329B | 32.97% | 280.33M |
FQ2 2021 (Apr 2021) | 6.57 | 6.57 | 0.279079B | 29.88% | 279.08M |
FQ1 2021 (Jan 2021) | 3 | 3 | 0.22826B | 18.19% | 228.26M |
FQ4 2020 (Oct 2020) | 3.2 | 3.2 | 0.22336B | 14.8% | 223.36M |
FQ3 2020 (Jul 2020) | 2.95 | 2.95 | 0.187911B | 8.53% | 187.91M |
FQ2 2020 (Apr 2020) | 1.4 | 1.4 | 0.195689B | 9.61% | 195.69M |
FQ4 Announce Date
07/30/2024 (Pre-Market)
Consensus EPS Estimates
0.54333
Consensus Revenue Estimates
0.378867333B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ2 2027 (Apr 2027) | 2.87 | -- | 2.87 | 2.87 | 0 |
FQ1 2027 (Jan 2027) | 2.24 | -- | 2.11967 | 2.37557 | 0 |
FQ4 2026 (Oct 2026) | 2.02 | -- | 2.02 | 2.02 | 0 |
FQ3 2026 (Jul 2026) | 1.41 | -- | 1.41 | 1.41 | 0 |
FQ1 2026 (Jan 2026) | 0.71 | -- | 0.67186 | 0.75297 | 0 |
FQ4 2025 (Oct 2025) | 1.85 | -- | 1.80672 | 1.89325 | 1 |
FQ3 2025 (Jul 2025) | 0.83 | -- | 0.81058 | 0.8494 | 1 |
FQ1 2025 (Jan 2025) | 0.24667 | -- | 0.23342 | 0.2616 | 1 |
FQ4 2024 (Oct 2024) | 1.16333 | -- | 1.13611 | 1.19052 | 0 |
FQ3 2024 (Jul 2024) | 0.54333 | -- | 0.35435 | 0.7205 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ2 2027 (Apr 2027) | 0.36B | -- | 0.36B | 0.36B | 1 |
FQ1 2027 (Jan 2027) | 0.33B | -- | 0.32B | 0.34B | 1 |
FQ4 2026 (Oct 2026) | 0.35B | -- | 0.35B | 0.35B | 1 |
FQ3 2026 (Jul 2026) | 0.34B | -- | 0.34B | 0.34B | 1 |
FQ1 2026 (Jan 2026) | 0.31B | -- | 0.3B | 0.32B | 1 |
FQ4 2025 (Oct 2025) | 0.38B | -- | 0.38B | 0.39B | 0 |
FQ3 2025 (Jul 2025) | 0.36B | -- | 0.36B | 0.37B | 0 |
FQ1 2025 (Jan 2025) | 0.33B | -- | 0.31B | 0.34B | 0 |
FQ4 2024 (Oct 2024) | 0.38B | -- | 0.37B | 0.38B | 1 |
FQ3 2024 (Jul 2024) | 0.38B | -- | 0.38B | 0.38B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Jan 2022) | 2.89 | 2.89 | 100% | |
FQ4 2021 (Oct 2021) | 3.5 | 3.5 | 100% | |
FQ3 2021 (Jul 2021) | 3.78 | 3.78 | 100% | |
FQ2 2021 (Apr 2021) | 6.57 | 6.57 | 100% | |
FQ1 2021 (Jan 2021) | 3 | 3 | 100% | |
FQ4 2020 (Oct 2020) | 3.2 | 3.2 | 100% | |
FQ3 2020 (Jul 2020) | 2.95 | 2.95 | 100% | |
FQ2 2020 (Apr 2020) | 1.4 | 1.4 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Jan 2022) | $0B | $0.29B | $291.9M | 100% |
FQ4 2021 (Oct 2021) | $0B | $0.29B | $288.3M | 100% |
FQ3 2021 (Jul 2021) | $0B | $0.28B | $280.33M | 100% |
FQ2 2021 (Apr 2021) | $0B | $0.28B | $279.08M | 100% |
FQ1 2021 (Jan 2021) | $0B | $0.23B | $228.26M | 100% |
FQ4 2020 (Oct 2020) | $0B | $0.22B | $223.36M | 100% |
FQ3 2020 (Jul 2020) | $0B | $0.19B | $187.91M | 100% |
FQ2 2020 (Apr 2020) | $0B | $0.2B | $195.69M | 100% |